Algert Global LLC Gritstone Bio, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $166,072 - $259,914	-18,958 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $36,549 - $77,205	-5,702 Reduced 23.12%	18,958 $205,000
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $200,485 - $251,531	24,660 New	24,660 $225,000
Q4 2020 Feb 12, 2021	SELL	$2.57 - $4.22 $53,970 - $88,620	-21,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.63 - $8.09 $55,230 - $169,890	21,000 New	21,000 $56,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.